Oxaliplatin-induced allergic reaction in patients with colorectal cancer in Japan

Medicine and Dentistry

• Adverse Event 50%
• Allergic Response 90%
• Allergy 10%
• Analysis 10%
• Antiallergic Agent 10%
• Chemotherapy 40%
• Clinical Feature 10%
• Fluorouracil 30%
• FOLFOX 10%
• Folinic Acid 30%
• Inpatient 10%
• Metastatic Carcinoma 10%
• Oxaliplatin 80%
• Patient 100%
• Platinum Derivative 10%
• Prophylaxis 10%
• Sex 10%
• Therapeutic Procedure 10%
• Toxicity 10%

Pharmacology, Toxicology and Pharmaceutical Science

• Adverse Event 50%
• Allergic Reaction 90%
• Allergy 10%
• Antiallergic Agent 10%
• Clinical Feature 10%
• Colorectal Cancer 50%
• Fluorouracil 30%
• Folinic Acid 30%
• Metastasis 10%
• Oxaliplatin 80%
• Patient History of Chemotherapy 10%
• Platinum Derivative 10%
• Toxicity 10%